Neuromuscular determinants of maximum walking speed in well-functioning older adults

David J. Clark, Todd M. Manini, Roger A. Fielding, Carolynn Patten

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Maximum walking speed may offer an advantage over usual walking speed for clinical assessment of age-related declines in mobility function that are due to neuromuscular impairment. The objective of this study was to determine the extent to which maximum walking speed is affected by neuromuscular function of the lower extremities in older adults. We recruited two groups of healthy, well functioning older adults who differed primarily on maximum walking speed. We hypothesized that individuals with slower maximum walking speed would exhibit reduced lower extremity muscle size and impaired plantarflexion force production and neuromuscular activation during a rapid contraction of the triceps surae muscle group (soleus (SO) and gastrocnemius (MG)).All participants were required to have usual 10-meter walking speed of > 1.0. m/s. If the difference between usual and maximum 10. m walking speed was < 0.6. m/s, the individual was assigned to the ". Slower" group (n = 8). If the difference between usual and maximum 10-meter walking speed was > 0.6. m/s, the individual was assigned to the ". Faster" group (n = 12). Peak rate of force development (RFD) and rate of neuromuscular activation (rate of EMG rise) of the triceps surae muscle group were assessed during a rapid plantarflexion movement. Muscle cross sectional area of the right triceps surae, quadriceps and hamstrings muscle groups was determined by magnetic resonance imaging.Across participants, the difference between usual and maximal walking speed was predominantly dictated by maximum walking speed (r = .85). We therefore report maximum walking speed (1.76 and 2.17. m/s in Slower and Faster, p. < .001) rather than the difference between usual and maximal. Plantarflexion RFD was 38% lower (p = .002) in Slower compared to Faster. MG rate of EMG rise was 34% lower (p = .01) in Slower than Faster, but SO rate of EMG rise did not differ between groups (p = .73). Contrary to our hypothesis, muscle CSA was not lower in Slower than Faster for the muscle groups tested, which included triceps surae (p = .44), quadriceps (p = .76) and hamstrings (p = .98). MG rate of EMG rise was positively associated with RFD and maximum 10. m walking speed, but not the usual 10. m walking speed.These findings support the conclusion that maximum walking speed is limited by impaired neuromuscular force and activation of the triceps surae muscle group. Future research should further evaluate the utility of maximum walking speed for use in clinical assessment to detect and monitor age-related functional decline.

Original languageEnglish (US)
Pages (from-to)358-363
Number of pages6
JournalExperimental Gerontology
Volume48
Issue number3
DOIs
StatePublished - Mar 1 2013
Externally publishedYes

Fingerprint

Muscle
Muscles
Chemical activation
Walking Speed
Lower Extremity
Skeletal Muscle
Quadriceps Muscle
Magnetic resonance
Magnetic Resonance Imaging
Imaging techniques

Keywords

  • Aging
  • Electromyography
  • Mobility
  • Muscle
  • Walking

ASJC Scopus subject areas

  • Biochemistry
  • Aging
  • Molecular Biology
  • Genetics
  • Endocrinology
  • Cell Biology

Cite this

Neuromuscular determinants of maximum walking speed in well-functioning older adults. / Clark, David J.; Manini, Todd M.; Fielding, Roger A.; Patten, Carolynn.

In: Experimental Gerontology, Vol. 48, No. 3, 01.03.2013, p. 358-363.

Research output: Contribution to journalArticle

Clark, David J. ; Manini, Todd M. ; Fielding, Roger A. ; Patten, Carolynn. / Neuromuscular determinants of maximum walking speed in well-functioning older adults. In: Experimental Gerontology. 2013 ; Vol. 48, No. 3. pp. 358-363.
@article{c80549aa24554efaaf1047d0b515658d,
title = "Neuromuscular determinants of maximum walking speed in well-functioning older adults",
abstract = "Maximum walking speed may offer an advantage over usual walking speed for clinical assessment of age-related declines in mobility function that are due to neuromuscular impairment. The objective of this study was to determine the extent to which maximum walking speed is affected by neuromuscular function of the lower extremities in older adults. We recruited two groups of healthy, well functioning older adults who differed primarily on maximum walking speed. We hypothesized that individuals with slower maximum walking speed would exhibit reduced lower extremity muscle size and impaired plantarflexion force production and neuromuscular activation during a rapid contraction of the triceps surae muscle group (soleus (SO) and gastrocnemius (MG)).All participants were required to have usual 10-meter walking speed of > 1.0. m/s. If the difference between usual and maximum 10. m walking speed was < 0.6. m/s, the individual was assigned to the {"}. Slower{"} group (n = 8). If the difference between usual and maximum 10-meter walking speed was > 0.6. m/s, the individual was assigned to the {"}. Faster{"} group (n = 12). Peak rate of force development (RFD) and rate of neuromuscular activation (rate of EMG rise) of the triceps surae muscle group were assessed during a rapid plantarflexion movement. Muscle cross sectional area of the right triceps surae, quadriceps and hamstrings muscle groups was determined by magnetic resonance imaging.Across participants, the difference between usual and maximal walking speed was predominantly dictated by maximum walking speed (r = .85). We therefore report maximum walking speed (1.76 and 2.17. m/s in Slower and Faster, p. < .001) rather than the difference between usual and maximal. Plantarflexion RFD was 38{\%} lower (p = .002) in Slower compared to Faster. MG rate of EMG rise was 34{\%} lower (p = .01) in Slower than Faster, but SO rate of EMG rise did not differ between groups (p = .73). Contrary to our hypothesis, muscle CSA was not lower in Slower than Faster for the muscle groups tested, which included triceps surae (p = .44), quadriceps (p = .76) and hamstrings (p = .98). MG rate of EMG rise was positively associated with RFD and maximum 10. m walking speed, but not the usual 10. m walking speed.These findings support the conclusion that maximum walking speed is limited by impaired neuromuscular force and activation of the triceps surae muscle group. Future research should further evaluate the utility of maximum walking speed for use in clinical assessment to detect and monitor age-related functional decline.",
keywords = "Aging, Electromyography, Mobility, Muscle, Walking",
author = "Clark, {David J.} and Manini, {Todd M.} and Fielding, {Roger A.} and Carolynn Patten",
year = "2013",
month = "3",
day = "1",
doi = "10.1016/j.exger.2013.01.010",
language = "English (US)",
volume = "48",
pages = "358--363",
journal = "Experimental Gerontology",
issn = "0531-5565",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Neuromuscular determinants of maximum walking speed in well-functioning older adults

AU - Clark, David J.

AU - Manini, Todd M.

AU - Fielding, Roger A.

AU - Patten, Carolynn

PY - 2013/3/1

Y1 - 2013/3/1

N2 - Maximum walking speed may offer an advantage over usual walking speed for clinical assessment of age-related declines in mobility function that are due to neuromuscular impairment. The objective of this study was to determine the extent to which maximum walking speed is affected by neuromuscular function of the lower extremities in older adults. We recruited two groups of healthy, well functioning older adults who differed primarily on maximum walking speed. We hypothesized that individuals with slower maximum walking speed would exhibit reduced lower extremity muscle size and impaired plantarflexion force production and neuromuscular activation during a rapid contraction of the triceps surae muscle group (soleus (SO) and gastrocnemius (MG)).All participants were required to have usual 10-meter walking speed of > 1.0. m/s. If the difference between usual and maximum 10. m walking speed was < 0.6. m/s, the individual was assigned to the ". Slower" group (n = 8). If the difference between usual and maximum 10-meter walking speed was > 0.6. m/s, the individual was assigned to the ". Faster" group (n = 12). Peak rate of force development (RFD) and rate of neuromuscular activation (rate of EMG rise) of the triceps surae muscle group were assessed during a rapid plantarflexion movement. Muscle cross sectional area of the right triceps surae, quadriceps and hamstrings muscle groups was determined by magnetic resonance imaging.Across participants, the difference between usual and maximal walking speed was predominantly dictated by maximum walking speed (r = .85). We therefore report maximum walking speed (1.76 and 2.17. m/s in Slower and Faster, p. < .001) rather than the difference between usual and maximal. Plantarflexion RFD was 38% lower (p = .002) in Slower compared to Faster. MG rate of EMG rise was 34% lower (p = .01) in Slower than Faster, but SO rate of EMG rise did not differ between groups (p = .73). Contrary to our hypothesis, muscle CSA was not lower in Slower than Faster for the muscle groups tested, which included triceps surae (p = .44), quadriceps (p = .76) and hamstrings (p = .98). MG rate of EMG rise was positively associated with RFD and maximum 10. m walking speed, but not the usual 10. m walking speed.These findings support the conclusion that maximum walking speed is limited by impaired neuromuscular force and activation of the triceps surae muscle group. Future research should further evaluate the utility of maximum walking speed for use in clinical assessment to detect and monitor age-related functional decline.

AB - Maximum walking speed may offer an advantage over usual walking speed for clinical assessment of age-related declines in mobility function that are due to neuromuscular impairment. The objective of this study was to determine the extent to which maximum walking speed is affected by neuromuscular function of the lower extremities in older adults. We recruited two groups of healthy, well functioning older adults who differed primarily on maximum walking speed. We hypothesized that individuals with slower maximum walking speed would exhibit reduced lower extremity muscle size and impaired plantarflexion force production and neuromuscular activation during a rapid contraction of the triceps surae muscle group (soleus (SO) and gastrocnemius (MG)).All participants were required to have usual 10-meter walking speed of > 1.0. m/s. If the difference between usual and maximum 10. m walking speed was < 0.6. m/s, the individual was assigned to the ". Slower" group (n = 8). If the difference between usual and maximum 10-meter walking speed was > 0.6. m/s, the individual was assigned to the ". Faster" group (n = 12). Peak rate of force development (RFD) and rate of neuromuscular activation (rate of EMG rise) of the triceps surae muscle group were assessed during a rapid plantarflexion movement. Muscle cross sectional area of the right triceps surae, quadriceps and hamstrings muscle groups was determined by magnetic resonance imaging.Across participants, the difference between usual and maximal walking speed was predominantly dictated by maximum walking speed (r = .85). We therefore report maximum walking speed (1.76 and 2.17. m/s in Slower and Faster, p. < .001) rather than the difference between usual and maximal. Plantarflexion RFD was 38% lower (p = .002) in Slower compared to Faster. MG rate of EMG rise was 34% lower (p = .01) in Slower than Faster, but SO rate of EMG rise did not differ between groups (p = .73). Contrary to our hypothesis, muscle CSA was not lower in Slower than Faster for the muscle groups tested, which included triceps surae (p = .44), quadriceps (p = .76) and hamstrings (p = .98). MG rate of EMG rise was positively associated with RFD and maximum 10. m walking speed, but not the usual 10. m walking speed.These findings support the conclusion that maximum walking speed is limited by impaired neuromuscular force and activation of the triceps surae muscle group. Future research should further evaluate the utility of maximum walking speed for use in clinical assessment to detect and monitor age-related functional decline.

KW - Aging

KW - Electromyography

KW - Mobility

KW - Muscle

KW - Walking

UR - http://www.scopus.com/inward/record.url?scp=84873891561&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873891561&partnerID=8YFLogxK

U2 - 10.1016/j.exger.2013.01.010

DO - 10.1016/j.exger.2013.01.010

M3 - Article

C2 - 23376102

AN - SCOPUS:84873891561

VL - 48

SP - 358

EP - 363

JO - Experimental Gerontology

JF - Experimental Gerontology

SN - 0531-5565

IS - 3

ER -